DCM Nouvelle Ltd

📊 DCM Nouvelle Q3 FY2025 Results: Mixed Performance with Notable Impairment Impact

• Standalone revenue from operations for Q3 2025: ₹26,921 lakhs

• Standalone net loss for Q3 2025: ₹3,390 lakhs

• Consolidated revenue from operations for Q3 2025: ₹27,253 lakhs

• Consolidated net loss for Q3 2025: ₹151 lakhs

• Exceptional items included ₹186 lakhs statutory impact from new Labour Codes

• Impairment provision of ₹3,561 lakhs for investment in subsidiary DCM Nouvelle Specialty Chemicals Limited

• Standalone EPS: negative ₹18.15 for Q3 2025

• Consolidated EPS: negative ₹0.59 for Q3 2025